Medtronic plc logo

Medtronic plc (MDT)

Market Closed
4 Jun, 20:00
NYSE NYSE
$
81. 93
+3.98
+5.1058%
$
94.98B Market Cap
25.14 P/E Ratio
2.84% Div Yield
19.43M Volume
5.2 Eps
$ 77.95
Previous Close
Add Transaction
Day Range
80 82.83
Year Range
73.31 106.33
Want to track MDT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?

MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?

The latest rate cut should help Medtronic expand in the AFib, structural heart, robotics, neuromodulation, hypertension and diabetes markets.

Zacks | 1 year ago
The Zacks Analyst Blog JPMorgan, Medtronic, Shopify and Perma-Pipe International

The Zacks Analyst Blog JPMorgan, Medtronic, Shopify and Perma-Pipe International

JPMorgan, Medtronic, Shopify and Perma-Pipe International are included in this Analyst Blog.

Zacks | 1 year ago
Medtronic (MDT) Advances But Underperforms Market: Key Facts

Medtronic (MDT) Advances But Underperforms Market: Key Facts

Medtronic (MDT) concluded the recent trading session at $88.26, signifying a +0.56% move from its prior day's close.

Zacks | 1 year ago
Medtronic voluntarily recalls insulin pumps due to risk of shortened battery life

Medtronic voluntarily recalls insulin pumps due to risk of shortened battery life

Company says the smallest knock can impact batteries by damaging internal electronics

Marketwatch | 1 year ago
Reasons to Retain Medtronic Stock in Your Portfolio Now

Reasons to Retain Medtronic Stock in Your Portfolio Now

Investors continue to be optimistic about Medtronic due to strength in its Neurosurgery portfolio. Yet, mounting expenses pose a threat to the company's margins.

Zacks | 1 year ago
Positive Trial Outcome for PulseSelect PFA Likely to Boost MDT Stock

Positive Trial Outcome for PulseSelect PFA Likely to Boost MDT Stock

Medtronic presents new clinical data on the PulseSelect PFA System and marks its launch in Japan.

Zacks | 1 year ago
Why Medtronic (MDT) is a Top Value Stock for the Long-Term

Why Medtronic (MDT) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 year ago
MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership

MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership

Medtronic expands AiBLE spine surgery ecosystem with new technologies and a partnership with Siemens Healthineers.

Zacks | 1 year ago
Medtronic (MDT) Up 0.7% Since Last Earnings Report: Can It Continue?

Medtronic (MDT) Up 0.7% Since Last Earnings Report: Can It Continue?

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 year ago
Medtronic: An Undervalued Stock With Durable Competitive Advantages

Medtronic: An Undervalued Stock With Durable Competitive Advantages

Medtronic, a global developer and manufacturer of medical devices for chronic diseases, is now a $111 billion (by market cap) healthcare behemoth. Medtronic has increased its dividend for 47 consecutive years, with a 10-year dividend growth rate of 9.8%. Medtronic advanced its revenue from $20.3 billion in FY 2015 to $32.4 billion in FY 2024, a compound annual growth rate of 5.3%.

Seekingalpha | 1 year ago
2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $200

2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $200

The best dividend stocks have a consistent history of paying and raising dividends in a wide range of economic landscapes. Medtronic is benefiting from its extensive portfolio of medical devices, and profits are growing.

Fool | 1 year ago
3 Reasons Medtronic's Stock Can Continue Rallying Higher

3 Reasons Medtronic's Stock Can Continue Rallying Higher

Medtronic has been consistently growing at around single digits for several quarters. The company has launched around 130 products in the past year.

Fool | 1 year ago
Loading...
Load More